Please login to the form below

Not currently logged in
Email:
Password:

Cardiome

This page shows the latest Cardiome news and features for those working in and with pharma, biotech and healthcare.

MSD strikes vernakalant deal with Astellas

In October 2003, Astellas US was granted an exclusive licence to develop and commercialise vernakalant iv in Canada, Mexico and the US by Cardiome Pharma Corp.

Latest news

  • The power of small

    Rhythm Search Developments (RSD), which evolved into Nortran Pharmaceuticals and subsequently Cardiome Pharma.

  • New drug approvals point to possible blockbusters

    The list includes the cholesterol drug Cordaptive from Merck &Co, the heart medication Kynapid (vernakalant) from Cardiome Pharma and the anaesthesia-complication drug Sugammadex from Schering-Plough. ... Kynapid from Cardiome Pharma would be the first

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Pharma deals during November 2013 Pharma deals during November 2013

    In a similar vein, Cardiome completed its acquisition of Correvio, a privately owned Swiss company (previously known as Iroko Cardio), achieving a European infrastructure for marketing its products. ... Cardiome has acquired Correvio through the purchase

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Merck & Co’s Jürgen Polifka joins Cardiome Merck & Co’s Jürgen Polifka joins Cardiome

    We are extremely pleased to have Dr Polifka join Cardiome at such a critical time in its history," said Karim Lalji, Cardiome's chief commercial officer. ... His personal experience with Brinavess at MSD and deep understanding of the European hospital

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Language barriers: Obesity has become a loaded word
...
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’....

Infographics